Inherent Raises $50M for AI-Native Science

A new venture, Inherent, has successfully closed a $50 million funding round, signaling a significant push into a novel paradigm of scientific discovery powered by artificial intelligence. The company, founded by former researchers from the renowned AI lab DeepMind, aims to redefine the scientific method by developing what it terms "AI-native science." This ambitious initiative seeks to leverage advanced AI capabilities to accelerate breakthroughs across various research disciplines.

The substantial capital infusion was led by prominent venture capital firm Index Ventures, underscoring strong investor confidence in Inherent's vision and the expertise of its founding team. The strategic backing from Index Ventures is particularly noteworthy, given the firm's track record of investing in transformative technology companies. The round also saw participation from other undisclosed investors, further validating the potential of Inherent's approach.

Inherent's core philosophy centers on building AI systems that can autonomously conduct scientific inquiry, moving beyond AI's current role as a tool for data analysis or hypothesis generation. The founders articulate a vision where AI actively participates in the entire research lifecycle, from formulating complex hypotheses to designing and executing experiments, and ultimately interpreting results. This represents a fundamental shift from traditional scientific workflows, which are heavily reliant on human intuition and manual processes.

The team behind Inherent brings a wealth of experience from DeepMind, a leader in artificial intelligence research, where they contributed to groundbreaking advancements in areas such as reinforcement learning and large-scale AI models. This deep technical background is expected to be instrumental in developing the sophisticated AI architectures required for "AI-native science." The company also benefits from strategic guidance, with Matt Clifford, co-founder of Entrepreneur First, serving as an advisor, bringing valuable insights into building and scaling deep-tech ventures.

The broader market for AI in scientific research is experiencing rapid growth, driven by the increasing complexity of scientific challenges and the potential for AI to unlock new avenues of discovery. Sectors like drug discovery, materials science, and climate modeling are prime candidates for this AI-driven revolution. Companies are increasingly looking to AI to reduce R&D timelines and costs, with recent reports indicating significant investment in AI-powered research platforms. Inherent's focus on a more integrated, AI-centric approach positions it to potentially capture a significant share of this evolving market.

With this significant funding, Inherent plans to expand its research and development team, further refine its AI platforms, and initiate pilot projects in key scientific domains. The company's success could pave the way for a new era of scientific exploration, where AI acts not just as an assistant, but as a true collaborator in the pursuit of knowledge. The implications for the pace of innovation and the nature of scientific discovery are profound.